Records containing: Plasma Cell Dyscrasia

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

All FDA submission records EMA medicine records ClinicalTrials.gov record updates ClinicalTrials.gov records with results posted

CLINICAL_TRIALS study record update · 2026-02-05
Pilot Trial of Homebound Stem Cell Transplantation
CLINICAL_TRIALS study record update · 2026-01-22
Integrated Cancer Repository for Cancer Research
CLINICAL_TRIALS study record update · 2025-03-17
A Comparison of Plerixafor/G-CSF With Chemotherapy/G-CSF for Stem Cell Mobilisation
CLINICAL_TRIALS study record update · 2024-02-26
Autologous Stem Cell Transplantation for Patients With AL Amyloidosis
CLINICAL_TRIALS study record update · 2023-02-09
Feasibility of a "Companion for CAR-T" Web App During Chimeric Antigen Receptor T-cell Therapy
Organize your saved records without ads with Plus.
CLINICAL_TRIALS study record update · 2022-11-03
Phase II Study of Shortened-duration Tacrolimus Following Nonmyeloablative Peripheral Blood Stem Cell Transplant With High-dose Posttransplantation Cyclophosphamide in Malignancies That Are Challenging to Engraft
CLINICAL_TRIALS study record update · 2020-05-11
A Diagnostic Screening Trial Seeking AL Amyloidosis Very Early
CLINICAL_TRIALS study record update · 2020-01-18
Phase I/II Study of Allogeneic Stem Cell Transplantation for Patients With Hematologic Malignancy, Using MHC Identical or Near Identical Donors and Sub-Myeloablative Conditioning With CAMPATH 1H (DIMSUM)
CLINICAL_TRIALS study record update · 2012-08-09
Reduced-Intensity Preparative Regiment With Fludarabine, Busulfan, And Alemtuzumab (Campath 1H) Followed By Allogeneic Hematopoietic Stem Cell Transplant For Malignant And Non-Malignant Hematological Diseases